A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer.
Loriot Y, Kalebasty AR, Fléchon A, Jain RK, Gupta S, Bupathi M, Beuzeboc P, Palmbos P, Balar AV, Kyriakopoulos CE, Pouessel D, Sternberg CN, Tonelli J, Sierecki M, Zhou H, Grivas P, Barthélémy P, Bangs R, Tagawa ST.
Loriot Y, et al. Among authors: tonelli j.
Future Oncol. 2024 Apr 29. doi: 10.2217/fon-2023-1030. Online ahead of print.
Future Oncol. 2024.
PMID: 38682560
Free article.
Review.